The First Medical Center

Tbilisi 0180

1 studies enrolling now · 6 studies all time

What they study most

Active Idiopathic Inflammatory Myopathy, Antisynthetase Syndrome, Dermatomyositis, Gout, Idiopathic Pulmonary Fibrosis (IPF), Immune-Mediated Necrotizing Myopathy, Myositis, Polymyositis

Studies at this site

• A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy. — Completed
• A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy — Enrolling by invitation
• Phase 2b/3 Study to Assess ABP-671 a Novel URAT1 Inhibitor in Participants With Gout — Completed
• A Study to Evaluate Safety and Efficacy of Empasiprubart in Adults With Dermatomyositis — Running, not enrolling
• Extension Study of ABP-671 in Participants With Gout — Stopped early
• A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) — Completed